-
1
AHNAK2: a potential diagnostic biomarker for pancreatic cancer related to cellular motility
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
2
Identification and validation of a novel autoantibody biomarker panel for differential diagnosis of pancreatic ductal adenocarcinoma
Published 2025-01-01Subjects: “…pancreatic ductal adenocarcinoma…”
Get full text
Article -
3
Elevated SAMD3 expression in T cells predicts improved survival in pancreatic ductal adenocarcinoma patients
Published 2025-02-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
4
CASC8 activates the pentose phosphate pathway to inhibit disulfidptosis in pancreatic ductal adenocarcinoma though the c-Myc-GLUT1 axis
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
5
-
6
The GLP-1R agonist semaglutide reshapes pancreatic cancer associated fibroblasts reducing collagen proline hydroxylation and favoring T lymphocyte infiltration
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
7
Assessing the diagnostic potential of SATB2 and β-catenin as biomarkers and therapeutic targets in pancreatic ductal adenocarcinoma
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
8
Epithelial–Mesenchymal Transition Suppression by ML210 Enhances Gemcitabine Anti-Tumor Effects on PDAC Cells
Published 2025-01-01Subjects: “…pancreatic ductal adenocarcinoma…”
Get full text
Article -
9
Multiphoton imaging-based quantifiable collagen signatures for predicting outcomes in patients with pancreatic ductal adenocarcinoma
Published 2025-02-01Subjects: Get full text
Article -
10
A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma
Published 2025-02-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
11
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Published 2023-04-01Subjects: Get full text
Article -
12
β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis
Published 2025-02-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
13
Single-cell transcriptomics analysis reveals dynamic changes and prognostic signature in tumor microenvironment of PDAC
Published 2025-02-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
14
Unveiling Microbiota Profiles in Saliva and Pancreatic Tissues of Patients with Pancreatic Cancer
Published 2025-01-01Subjects: “…pancreatic ductal adenocarcinoma…”
Get full text
Article -
15
Characterizing immune biomarkers and effector CD8+ T-cell exhaustion in pancreatic adenocarcinoma via single-cell RNA sequencing profiling
Published 2025-01-01Subjects: “…pancreatic ductal adenocarcinoma…”
Get full text
Article -
16
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
17
Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer
Published 2025-01-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
18
Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy
Published 2025-04-01Subjects: “…Pancreatic ductal adenocarcinoma…”
Get full text
Article -
19
It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
Published 2025-01-01Subjects: “…pancreatic ductal adenocarcinoma…”
Get full text
Article -
20